ARTICLE AD BOX
![]()
Most people think of anemia as a fatigue problem, you're pale, you're tired, your doctor tells you to eat more spinach. What they don't tell you is that low hemoglobin might also be quietly nudging your brain toward dementia.
A new study published April 17, 2026 in JAMA Network Open journal is making exactly that case, and the findings are hard to ignore.Researchers from Karolinska Institutet and Stockholm University followed over 2,200 dementia-free older adults from a Swedish population cohort called SNAC-K. They tracked participants across years, measured their hemoglobin levels, and tested their blood for four well-known markers of Alzheimer's disease — p-tau217, GFAP, NfL, and amyloid-beta proteins. The goal was simple but focused: does anemia connect, in any meaningful way, to the biological processes that drive Alzheimer's?The answer was yes. Anemia was linked, right from the baseline assessment, to higher levels of Alzheimer's disease blood biomarkers, and over the follow-up period, it was also associated with a greater risk of developing dementia. Not only did people with anemia already show elevated markers of brain pathology when they entered the study, but they were also more likely to actually develop dementia later. The highest dementia risk occurred when low hemoglobin and elevated Alzheimer's disease biomarkers coexisted, suggesting a potential interplay between anemia and neuropathology in dementia development.
Why would a blood disorder affect the brain like this?
The most plausible explanation runs through oxygen. When hemoglobin is low, less oxygen reaches the brain. Chronic low-grade hypoxia, even the kind that doesn't cause obvious symptoms, can damage neurons over time, accelerate neuroinflammation, and likely push up levels of proteins like GFAP and NfL that signal brain cell stress and injury. The brain is an extraordinarily oxygen-dependent organ. Deprive it consistently, and there are consequences.The researchers were careful to note this is observational work. They adjusted for a wide range of confounders including kidney disease, heart conditions, inflammation markers, and APOE ε4 genetic status. But the patterns held. And the fact that the relationship between hemoglobin levels and dementia risk appeared, meaning the lower the hemoglobin, the higher the risk, lends the findings real biological plausibility.What this means practically is that anemia in older adults probably deserves more clinical attention than it gets.
The iron problem is bigger than you think
Iron deficiency is very common. Roughly 1.62 billion people worldwide are affected by anemia, and iron deficiency is the leading cause in most settings. That's nearly one in four people on the planet walking around with blood that's struggling to do its job.India is where the numbers get truly alarming. The most recent national data, from the 2019–21 health survey, shows that two in three children under five were anemic, as were more than half of women aged 15–49 and a quarter of men in the same age group. What's particularly unsettling is that this isn't improving. The most recent official data shows an increased prevalence compared to 2015–16 — meaning that despite years of iron supplementation programmes, the needle hasn't moved in the right direction. A UK study analysing over 31,000 people found an overall anemia prevalence of 6%, rising to nearly 1 in 10 among women, with the highest rates in females of menstruating age. Low iron stores were found in 24% of adolescent girls in the UK, a figure that rarely gets the attention it deserves. In Australia, around 12% of women, 8% of preschool-aged children, and 20% of people over 85 are anemic, and in some regional areas the situation is far worse.In the US, the picture is similarly uneven. Between 5 and 10% of premenopausal American women and 2–5% of men have iron deficiency anemia, with pregnant women and young children carrying a disproportionate share of that burden. So no, this isn't just a developing-world issue. It's everywhere.



English (US) ·